modelTigecycline_Bastida2022_reference

Extends from Pharmacolibrary.Pharmacokinetic.Models.PK_1C.

Information

name:tigecycline
ATC code:J01AA12
model:one compartment, IV dosing (PK_1C)
source:Bastida C et al. 2022
population:critically ill patients with decompensated cirrhosis and severe infections
measured compound:tigecycline
review:curated candidate
record page:pharmacolibrary-docs

Parameters as reported in the paper

parametervalueunitmeaning
clearance (CL)14.8L/hCL
intercompartmental clearance (Q)38.4L/hQ
central and peripheral volumes of distribution (V1 and V2)63.7LV

About tigecycline

Tigecycline is a tetracycline antibiotic used to treat bacterial infections, including pneumonia and complicated skin, soft tissue, and intra-abdominal infections. It is authorised in the European Union and used mainly in hospital settings for serious bacterial infections.

Summary written by glm-5.3-flash from Wikidata Q420595 and the WHO ATC classification and the EMA medicines list; not checked by a person.

Identity, molar mass and metabolites: Tigecycline.

References

  1. Bastida C et al. (2022). Tigecycline population pharmacokinetics in critically ill patients with decompensated cirrhosis and severe infections. The Journal of antimicrobial chemotherapy 77(5):1365–1371. DOI:10.1093/jac/dkac036 PUBMED:35178567

Parameters

TypeNameDefaultDescription
RealCl_ref4.111111111111111e-06Cl [m3/s]
RealVd_ref0.0637Vd [m3]
Modelica.Units.SI.Massweight (from PK_1C)75patient weight (kg)
Modelica.Units.SI.SpecificVolumeVdPerKg (from PK_1C)0.0009Volume of distribution per kg (default 0.9 L/kg)
Modelica.Units.SI.MassFractionF (from PK_1C)1bioavailability (0-1)
Pharmacolibrary.Types.ClearanceCl (from PK_1C)2.7777777777777776e-7clearance
Modelica.Units.SI.TimeadminTime (from PK_1C)60first administration time (s)
Modelica.Units.SI.TimeadminDuration (from PK_1C)600administration duration (s)
Modelica.Units.SI.TimeadminPeriod (from PK_1C)8*60*60period of administration (default 8 hours)(s)
Pharmacolibrary.Types.MassadminMass (from PK_1C)1e-4administration mass (mg)
IntegeradminCount (from PK_1C)8number of dose administered (1)
Pharmacolibrary.Types.VolumeVd (from PK_1C)VdPerKg*weightVolume of distribution (m3)
Info › Therapeutic range (metadata, not used in equations)
Pharmacolibrary.Types.MassConcentrationCmin (from PK_1C)0.004minimal therapeutic range
Pharmacolibrary.Types.MassConcentrationCmax (from PK_1C)0.008maximal therapeutic range
Pharmacolibrary.Types.MassConcentrationCtox_peak (from PK_1C)0.012toxicity peak level
Pharmacolibrary.Types.MassConcentrationCtox_trough (from PK_1C)0.006toxicity trough level
Info › Substance metadata
Modelica.Units.SI.MolarMassMM (from PK_1C)0molar mass [kg/mol]; 0 = not supplied (molar concentrations are then 0)
Info › Substance metadata (not used in equations)
Pharmacolibrary.Types.DoseLD50 (from PK_1C)0median lethal dose [mg/kg]; 0 = unknown

Connectors

TypeNameDefaultDescription
Types.ConcentrationOutputC_central (from PK_1C)
Interfaces.ConcentrationPort_bcentralCPort (from PK_1C)

Components

TypeNameDefaultDescription
Pharmacokinetic.NoPerfusedTissueCompartmentcentral (from PK_1C)
Pharmacokinetic.ClearanceDrivenEliminationelim (from PK_1C)
Sources.PeriodicDoseperiodicDose (from PK_1C)
Modelica.Units.SI.Timet1_2 (from PK_1C)central-compartment elimination half-life = ln(2)*Vd/Cl (1-compartment approximation; NOT the terminal half-life of 2-/3-compartment models)

Revisions

  • 11/2026 generated by pharmacolibrary-dev export.pharmacolibrary_models from Bastida_2022: parameters extracted from the paper by the pharmacolibrary-dev pipeline, model built by its engineer, reviewed: curated candidate